Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCP in Relapsed/Refractory Multiple Myeloma
NCT01166113Phase 2Completed
- Sponsor
- Fondazione EMN Italy
- Start
- Jul 2010
- Primary completion
- Jun 2011
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in multiple myeloma (MM), sponsored by Fondazione EMN Italy. Started Jul 2010; status: completed.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01166113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01166113.